Neuberger Berman Group LLC Alnylam Pharmaceuticals, Inc. Transaction History

Neuberger Berman Group LLC

$123 Billion
Q3 2024

A detailed history of Neuberger Berman Group LLC transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Neuberger Berman Group LLC holds 106,197 shares of ALNY stock, worth $26.9 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

106,197

Previous 95,408 11.31%

Holding current value

$26.9 Million

Previous $23.2 Million 26.0%

% of portfolio

0.02%

Previous 0.02%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$233.81 - $287.01 $2.52 Million - $3.1 Million	10,789 Added 11.31%	106,197 $29.2 Million
Q2 2024 Nov 14, 2024	BUY	$143.31 - $247.0 $581,551 - $1 Million	4,058 Added 4.44%	95,408 $23.2 Million
Q2 2024 Aug 13, 2024	BUY	$143.31 - $247.0 $581,551 - $1 Million	4,058 Added 4.44%	95,408 $23.2 Million
Q1 2024 Nov 14, 2024	BUY	$146.51 - $198.2 $2.88 Million - $3.9 Million	19,686 Added 27.47%	91,350 $13.7 Million
Q1 2024 May 13, 2024	BUY	$146.51 - $198.2 $13.4 Million - $18.1 Million	91,350 New	91,350 $13.7 Million
Q4 2023 Nov 14, 2024	SELL	$151.41 - $196.57 $3.6 Million - $4.67 Million	-23,744 Reduced 24.89%	71,664 $13.7 Million
Q4 2023 Feb 09, 2024	SELL	$151.41 - $196.57 $2.75 Million - $3.57 Million	-18,176 Reduced 20.23%	71,664 $13.7 Million
Q3 2023 Nov 14, 2023	SELL	$170.77 - $211.65 $1,536 - $1,904	-9 Reduced 0.01%	89,840 $15.9 Million
Q2 2023 Aug 11, 2023	BUY	$185.01 - $212.05 $73,448 - $84,183	397 Added 0.44%	89,849 $17.1 Million
Q1 2023 May 12, 2023	BUY	$182.66 - $235.53 $5.24 Million - $6.76 Million	28,682 Added 47.2%	89,452 $17.9 Million
Q4 2022 Feb 13, 2023	BUY	$185.53 - $241.31 $10.4 Million - $13.5 Million	55,952 Added 1161.31%	60,770 $14.4 Million
Q3 2022 Nov 15, 2022	BUY	$138.54 - $232.0 $17,040 - $28,536	123 Added 2.62%	4,818 $965,000
Q2 2022 Aug 15, 2022	SELL	$120.42 - $169.29 $191,467 - $269,171	-1,590 Reduced 25.3%	4,695 $685,000
Q1 2022 May 13, 2022	BUY	$127.18 - $173.91 $328,633 - $449,383	2,584 Added 69.82%	6,285 $953,000
Q4 2021 Feb 11, 2022	BUY	$159.56 - $209.29 $590,531 - $774,582	3,701 New	3,701 $553,000
Q1 2019 May 13, 2019	SELL	$72.76 - $93.45 $208,893 - $268,294	-2,871 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$87.52 - $122.67 $38,333 - $53,729	-438 Reduced 13.24%	2,871 $251,000
Q2 2018 Aug 13, 2018	BUY	$88.31 - $107.8 $56,783 - $69,315	643 Added 24.12%	3,309 $326,000
Q3 2017 Nov 15, 2017	BUY	$72.53 - $118.27 $193,364 - $315,307	2,666	2,666 $313,000

Others Institutions Holding ALNY

# of Institutions

644

Shares Held

109M

Call Options Held

1.28M

Put Options Held

1.21M

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $31.2B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Neuberger Berman Group LLC with notifications on news.

Account

Neuberger Berman Group LLC Alnylam Pharmaceuticals, Inc. Transaction History